Current Protein Identity:Q9Y279 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2ICC Extracellular Domain of CRIg Deposited 2006-09-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–137(119 aa) Fragment:extracellular domain of CRIG
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 6.4;298 K;pH 6.4, EVAPORATION, temperature 298K
Resolution 1.20 Å R-free 0.172
2ICE CRIg bound to C3c Deposited 2006-09-12 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain S 19–137(119 aa)
Not recorded CA CALCIUM ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 3.10 Å R-free 0.295
2ICE CRIg bound to C3c Deposited 2006-09-12 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain T 19–137(119 aa)
Not recorded CA CALCIUM ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 3.10 Å R-free 0.295
2ICF CRIg bound to C3b Deposited 2006-09-12 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain S 19–137(119 aa)
Not recorded CA CALCIUM ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 6.5;293 K;pH 6.5, EVAPORATION, temperature 293K
Resolution 4.10 Å R-free 0.330
5IMK Nanobody targeting human Vsig4 in Spacegroup C2 Deposited 2016-03-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–232(214 aa) Fragment:UNP residues 19-232
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1M Sodium citrate tribasic dehydrate pH5.6, 20% 2-Propanol, 20% PEG 4000
Resolution 1.23 Å R-free 0.185
5IML Nanobody targeting human Vsig4 in Spacegroup P212121 Deposited 2016-03-06 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–232(214 aa) Fragment:UNP residues 19-232
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;(1) 1.2M sodium citrate tribasic dehydrate, 0.1M BIS-TRIS propane pH7.0 and (2) 0.17M Ammonium sulfate, 15% Glycerol, 25.5% PEG 4000
Resolution 1.80 Å R-free 0.226
8TE5 Crystal structure of a multiple lysine-to-arginine substitution mutant of the human CRIg C3b-binding domain Deposited 2023-07-05 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 20–137(118 aa)
Mutation:K15R,K36R,K62R,K72R,K110R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium aaetate (pH 6.5) 0.2 M ammonium acetate 30% (w/v) peg-4000
Resolution 1.50 Å R-free 0.223
8TE6 Crystal structure of a multiple lysine-to-arginine substitution mutant of the human CRIg C3b-binding domain Deposited 2023-07-05 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 20–137(118 aa)
Mutation:K15R,K36R,K62R,K72R,K110R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium acetate (pH 6.5) 0.2 M ammonium acetate 30% (w/v) PEG-4000
Resolution 1.25 Å R-free 0.196
9EZH Structure of single-domain antibody VHH_h4 in complex with human Vsig4 Deposited 2024-04-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 20–137(118 aa)
Not recorded GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0,1M Bis-Tris pH 6.0 and 24% PEG3350
Resolution 1.94 Å R-free 0.239
9EZI Structure of single-domain antibody VHH_h5 in complex with human Vsig4 Deposited 2024-04-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 20–137(118 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0,1M Bis-Tris pH 6.5 and 30% PEG3350
Resolution 1.97 Å R-free 0.243
9EZU Structure of the single-domain antibody VHH_h1 in complex with human Vsig4 Deposited 2024-04-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 20–137(118 aa)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;287 K;0,17M ammonium sulfate 15% glycerol 25,5% PEG 4000
Resolution 1.05 Å R-free 0.176
9EZV Structure of the single-domain antibody VHH_h2 in complex with human Vsig4 Deposited 2024-04-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 20–137(118 aa)
Not recorded EDO 1,2-ETHANEDIOL × 8 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;287 K;0,1M Na-citrate pH 5,6 20% 2-propanol 21% PEG 4000
Resolution 1.45 Å R-free 0.215
9EZW Structure of the single-domain antibody VHH_h3 in complex with human Vsig4 Deposited 2024-04-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 20–137(118 aa)
Not recorded EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;294 K;0,1M Na-citrate pH 5,6 20% 2-propanol 21% PEG 4000
Resolution 1.90 Å R-free 0.228
9EZW Structure of the single-domain antibody VHH_h3 in complex with human Vsig4 Deposited 2024-04-14 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 20–137(118 aa)
Not recorded EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;294 K;0,1M Na-citrate pH 5,6 20% 2-propanol 21% PEG 4000
Resolution 1.90 Å R-free 0.228
9EZW Structure of the single-domain antibody VHH_h3 in complex with human Vsig4 Deposited 2024-04-14 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 20–137(118 aa)
Not recorded EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;294 K;0,1M Na-citrate pH 5,6 20% 2-propanol 21% PEG 4000
Resolution 1.90 Å R-free 0.228
9EZW Structure of the single-domain antibody VHH_h3 in complex with human Vsig4 Deposited 2024-04-14 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 20–137(118 aa)
Not recorded EDO 1,2-ETHANEDIOL × 4 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;294 K;0,1M Na-citrate pH 5,6 20% 2-propanol 21% PEG 4000
Resolution 1.90 Å R-free 0.228